#COPDChat Tweet Chat

@Boehringer have hosted two Tweetchats so far using #COPDChat covering topics such as inhaler device choice, the role of digital and social media in patient treatment adherence, unmet treatment needs and the role of dual bronchodilation in COPD treatment. We welcome your thoughts on future topics for #COPDChat, please contact us at askbi @ boehringer-ingelheim.com or on Twitter if you have any suggestions. In the white paper below Boehringer Ingelheim explore why it is critical for pharma to engage with the Twitter community via Tweetchats to inform, connect and build trust between pharmaceutical companies and broader healthcare stakeholders. http://bit.ly/1slaHso

#COPDChat is a healthcare tweet chat hashtag submitted by @Boehringer